Literature DB >> 35110048

Mesenchymal Stem Cell Transplantation for COVID-19 Treatment in a Puerperium Period in Intensive Care Unit.

Ayca Sultan Sahin1, Ebru Kaya1, Gursel Turgut2, Kemal Dolay3, Ali Kocatas1.   

Abstract

Entities:  

Year:  2021        PMID： 35110048      PMCID： PMC9053684          DOI： 10.5152/TJAR.2021.1235

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN： 2149-276X


× No keyword cloud information.
  4 in total

Review 1.  Biological functions of mesenchymal stem cells and clinical implications.

Authors:  Abderrahim Naji; Masamitsu Eitoku; Benoit Favier; Frédéric Deschaseaux; Nathalie Rouas-Freiss; Narufumi Suganuma
Journal:  Cell Mol Life Sci       Date:  2019-05-04       Impact factor: 9.261

2.  Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A(H5N1) Virus-Associated Acute Lung Injury.

Authors:  Hayley Loy; Denise I T Kuok; Kenrie P Y Hui; Miranda H L Choi; W Yuen; John M Nicholls; J S Malik Peiris; Michael C W Chan
Journal:  J Infect Dis       Date:  2019-01-07       Impact factor: 5.226

3.  Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model.

Authors:  Dexiao Kong; Xia Liu; Xiaomei Li; Jianting Hu; Xiaoyan Li; Juan Xiao; Yibo Dai; Mingming He; Xiaoli Liu; Yang Jiang; Ruodi Cui; Lihong Zhang; Juandong Wang; Ai Li; Fang Wang; Yuan Zhang; Juan Xiao; Wei Wang; Chengyun Zheng
Journal:  Biosci Rep       Date:  2019-09-16       Impact factor: 3.840

4.  Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.

Authors:  Ashok K Shetty
Journal:  Aging Dis       Date:  2020-03-09       Impact factor: 6.745
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.